España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
M&A
Mmm, Mmm Mergers: M&A In The Food Sector
Baird: RPX Corp. Buyout Would Be An 'Incremental Positive'
Cowen Names Marvell A 'Best Idea' For 2018
Baird: RPX Corp. Buyout Would Be An 'Incremental Positive'
Cowen Names Marvell A 'Best Idea' For 2018
A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers
Report: SiriusXM In Talks To Acquire Pandora
A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers
Report: SiriusXM In Talks To Acquire Pandora
JPMorgan And GE's Business Relationship Is More Than 100 Years Old
Kate Spade Spikes 17% Amid M&A Speculation
Read More...
M&A Recent News
Centurylink, Level 3 Confirm $34 Billion Deal
Filing Details Microsoft And Salesforce's Bidding War For LinkedIn
JPMorgan's Global Chairman On Tech M&A: 'Scale Does Matter And Competition Is Fierce'
Citigroup's Co-Head Of Global M&A Discusses His Outlook
Evercore's Roger Altman Discusses M&A Activity
Perrigo Spikes After Rumors It's Withdrawing From Leerink Conference
Merger Landscape Still Inviting To Inversions
Alibaba's Youku Tudou Purchase Just The Latest In High Premium M&A Deals
Report: Bass Pro Shops Working On Potential Deal For Cabelas
Visa, Shire The Latest Adding To Merger Frenzy
Merger Monday: Nine Deals You Might Have Missed
IntraLinks Deal Flow Predictor: Global M&A Activity To Show Modest Q1 Growth In 2016
Black Diamond Stock Falling After Tweet
Is The M&A Boom Over? We May Have An Answer Soon
Why M&A Doesn't Make Sense For Pfizer Anytime Soon
Canaccord Genuity: Buy This 'HOT' Stock
Celgene-Receptos: How Wall Street Is Reacting
Barclays Expects M&A In Specialty Pharma To Continue, Likes Valeant And Jazz
4 REITs That Could See M&A Activity Soon
Healthcare Companies Most Hit By Hackers Stealing M&A Data
Why Does This Hedge Fund Invest In Small- And Mid-Cap Banks?
Who's The Next Big Pharma Acquisition?
Valeant CEO: Healthcare Sector A 'Bit Of A Bubble'